12:00 AM
 | 
May 11, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Isis preclinical data

In animals, a hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1, HDL) antisense inhibitor reduced triglycerides in both...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >